Literature DB >> 18359287

Two novel VHL targets, TGFBI (BIGH3) and its transactivator KLF10, are up-regulated in renal clear cell carcinoma and other tumors.

Sergey V Ivanov1, Alla V Ivanova, Konstantin Salnikow, Olga Timofeeva, Malayannan Subramaniam, Michael I Lerman.   

Abstract

Mutations in the VHL gene are associated with highly vascular tumors of kidney, brain, retina, and adrenal gland. The inability of the mutant VHL protein to destabilize HIF-1 plays a crucial role in malignant angiogenesis. VHL is also associated with ECM assembly but the molecular mechanisms of this activity remain unclear. We used expression arrays and cell lines with different VHL status to identify ECM-associated genes controlled by VHL. One of them, adhesion-associated TGFBI, was repressed by VHL and overexpressed in renal, gastrointestinal, brain, and other tumors. Analyzing the mechanism of TGFBI up-regulation in clear cell carcinoma, we identified a novel VHL target, a Kruppel-like transcriptional factor 10 (KLF10). The TGFBI promoter, which we isolated and studied in Luc-reporter assay, was induced by KLF10 but not hypoxia. These data provide the molecular basis for the observed VHL effect on TGFBI and stimulate further research into the KLF10 and TGFBI roles in cancer.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18359287      PMCID: PMC2413015          DOI: 10.1016/j.bbrc.2008.03.066

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  45 in total

1.  von Hippel-Lindau protein promotes the assembly of actin and vinculin and inhibits cell motility.

Authors:  M Kamada; K Suzuki; Y Kato; H Okuda; T Shuin
Journal:  Cancer Res       Date:  2001-05-15       Impact factor: 12.701

2.  Regulation of STRA13 by the von Hippel-Lindau tumor suppressor protein, hypoxia, and the UBC9/ubiquitin proteasome degradation pathway.

Authors:  A V Ivanova; S V Ivanov; A Danilkovitch-Miagkova; M I Lerman
Journal:  J Biol Chem       Date:  2001-02-06       Impact factor: 5.157

3.  VHL induces renal cell differentiation and growth arrest through integration of cell-cell and cell-extracellular matrix signaling.

Authors:  E J Davidowitz; A R Schoenfeld; R D Burk
Journal:  Mol Cell Biol       Date:  2001-02       Impact factor: 4.272

4.  DEC1 is a downstream target of TGF-beta with sequence-specific transcriptional repressor activities.

Authors:  Leigh Zawel; Jian Yu; Christopher J Torrance; Sanford Markowitz; Kenneth W Kinzler; Bert Vogelstein; Shibin Zhou
Journal:  Proc Natl Acad Sci U S A       Date:  2002-03-05       Impact factor: 11.205

5.  The transforming growth factor-beta-inducible matrix protein (beta)ig-h3 interacts with fibronectin.

Authors:  Paul C Billings; J Charles Whitbeck; Christopher S Adams; William R Abrams; Arthur J Cohen; Beatrice N Engelsberg; Pamela S Howard; Joel Rosenbloom
Journal:  J Biol Chem       Date:  2002-05-28       Impact factor: 5.157

6.  Beta IGH3, a TGF-beta inducible gene, is overexpressed in lung cancer.

Authors:  Hidefumi Sasaki; Yoshihiro Kobayashi; Yoshiaki Nakashima; Satoru Moriyama; Haruhiro Yukiue; Masahiro Kaji; Masanobu Kiriyama; Ichiro Fukai; Yosuke Yamakawa; Yoshitaka Fujii
Journal:  Jpn J Clin Oncol       Date:  2002-03       Impact factor: 3.019

7.  Role of the von Hippel-Lindau tumor suppressor gene in the formation of beta1-integrin fibrillar adhesions.

Authors:  Miguel A Esteban-Barragán; Pilar Avila; Miguel Alvarez-Tejado; M Dolores Gutiérrez; Angeles García-Pardo; Francisco Sánchez-Madrid; Manuel O Landázuri
Journal:  Cancer Res       Date:  2002-05-15       Impact factor: 12.701

8.  BetaIg-h3 is involved in the HAb18G/CD147-mediated metastasis process in human hepatoma cells.

Authors:  Juan Tang; Hong-wei Zhou; Jian-li Jiang; Xiang-min Yang; Yu Li; Hong-xin Zhang; Zhi-nan Chen; Wei-ping Guo
Journal:  Exp Biol Med (Maywood)       Date:  2007-03

9.  Secreted and cell surface genes expressed in benign and malignant colorectal tumors.

Authors:  P Buckhaults; C Rago; B St Croix; K E Romans; S Saha; L Zhang; B Vogelstein; K W Kinzler
Journal:  Cancer Res       Date:  2001-10-01       Impact factor: 12.701

10.  Identification of cyclin D1 and other novel targets for the von Hippel-Lindau tumor suppressor gene by expression array analysis and investigation of cyclin D1 genotype as a modifier in von Hippel-Lindau disease.

Authors:  Malgorzata Zatyka; Nancy Fernandes da Silva; Steven C Clifford; Mark R Morris; Michael S Wiesener; Kai-Uwe Eckardt; Richard S Houlston; Frances M Richards; Farida Latif; Eamonn R Maher
Journal:  Cancer Res       Date:  2002-07-01       Impact factor: 12.701

View more
  38 in total

1.  Analysis of the human pancreatic stellate cell secreted proteome.

Authors:  Angela Y Wehr; Emma E Furth; Vineet Sangar; Ian A Blair; Kenneth H Yu
Journal:  Pancreas       Date:  2011-05       Impact factor: 3.327

2.  Decreased expression of receptor tyrosine kinase of EphB1 protein in renal cell carcinomas.

Authors:  Shuigen Zhou; Longxin Wang; Guimei Li; Zhengyu Zhang; Jiandong Wang
Journal:  Int J Clin Exp Pathol       Date:  2014-06-15

3.  HOXC4 homeoprotein efficiently expands human hematopoietic stem cells and triggers similar molecular alterations as HOXB4.

Authors:  Céline Auvray; Andrée Delahaye; Françoise Pflumio; Rima Haddad; Sophie Amsellem; Ayda Miri-Nezhad; Loïc Broix; Azzedine Yacia; Frédérique Bulle; Serge Fichelson; Isabelle Vigon
Journal:  Haematologica       Date:  2012-02       Impact factor: 9.941

Review 4.  Functional role of KLF10 in multiple disease processes.

Authors:  Malayannan Subramaniam; John R Hawse; Nalini M Rajamannan; James N Ingle; Thomas C Spelsberg
Journal:  Biofactors       Date:  2010 Jan-Feb       Impact factor: 6.113

5.  A gene expression signature of invasive potential in metastatic melanoma cells.

Authors:  Aaron R Jeffs; Amy C Glover; Lynn J Slobbe; Li Wang; Shujie He; Jody A Hazlett; Anshul Awasthi; Adele G Woolley; Elaine S Marshall; Wayne R Joseph; Cristin G Print; Bruce C Baguley; Michael R Eccles
Journal:  PLoS One       Date:  2009-12-24       Impact factor: 3.240

6.  TGFBI expression is associated with a better response to chemotherapy in NSCLC.

Authors:  Marta Irigoyen; María J Pajares; Jackeline Agorreta; Mariano Ponz-Sarvisé; Elisabeth Salvo; María D Lozano; Ruben Pío; Ignacio Gil-Bazo; Ana Rouzaut
Journal:  Mol Cancer       Date:  2010-05-28       Impact factor: 27.401

7.  TGFBI protein high expression predicts poor prognosis in colorectal cancer patients.

Authors:  Jing Zhu; Xijun Chen; Zhongcai Liao; Chao He; Xiaotong Hu
Journal:  Int J Clin Exp Pathol       Date:  2015-01-01

8.  βig-h3 potentiates the profibrogenic effect of TGFβ signaling on connective tissue progenitor cells through the negative regulation of master chondrogenic genes.

Authors:  Carlos I Lorda-Diez; Juan A Montero; Manuel J Diaz-Mendoza; Juan A Garcia-Porrero; Juan M Hurle
Journal:  Tissue Eng Part A       Date:  2012-10-24       Impact factor: 3.845

9.  Improving the efficiency of biomarker identification using biological knowledge.

Authors:  John H Phan; Qiqin Yin-Goen; Andrew N Young; May D Wang
Journal:  Pac Symp Biocomput       Date:  2009

10.  Expression analysis of human pterygium shows a predominance of conjunctival and limbal markers and genes associated with cell migration.

Authors:  C J Jaworski; M Aryankalayil-John; M M Campos; R N Fariss; J Rowsey; N Agarwalla; T W Reid; N Dushku; C A Cox; D Carper; G Wistow
Journal:  Mol Vis       Date:  2009-11-20       Impact factor: 2.367

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.